来自免疫检查点抑制剂的免疫相关不良事件的知识领域和新兴趋势:一个参考资料和可视化分析

Jun Zhao1, Yujie Feng2, Guang-Wei Liu3

  • 1Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266003, China.

Heliyon
|March 22, 2024
PubMed
概括

免疫检查点抑制剂 (ICI) 的免疫相关不良事件 (irAEs) 的研究正在增长. 未来的趋势包括专注于病例报告和了解黑色素瘤和肺癌中的irAEs.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K